IP6K1 and cerebral infarction: Our study provides new evidence that i-HPK1 suppresses neutrophil hyperactivation by blocking NF-κB/STAT3/p38-MAPK and GSDMD pathways and neutrophil trafficking into the brain and lungs, ultimately alleviating cerebral infarction and pulmonary injury following AIS.